Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YY001 for Adult Upper Limb Spasticity (REHAB-1)
CTR20254839Phase 3Active
- Sponsor
- Yuyan Pharma
- Start
- Dec 2025
- Modality
- Bacterial Toxin Conjugates → Immunotoxins → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of JHM03 in upper extremity spasticity, sponsored by Yuyan Pharma. Started Dec 2025; status: active.
02
Drugs
JHM03
03
Conditions
upper extremity spasticity
Beyond the preview
Go deeper on CTR20254839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254839.